DIKUL - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov UL. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 207
1.
  • Utility of baseline 18FDG-P... Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
    Ceriani, Luca; Martelli, Maurizio; Zinzani, Pier Luigi ... Blood, 08/2015, Letnik: 126, Številka: 8
    Journal Article
    Recenzirano
    Odprti dostop

    The International Extranodal Lymphoma Study Group (IELSG) 26 study was designed to evaluate the role of 18F-fluorodeoxyglucose (18FDG) positron emission tomography/computed tomography (PET/CT) in the ...
Celotno besedilo
Dostopno za: UL

PDF
2.
  • Early Interim 2-[18F]Fluoro... Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
    GALLAMINI, Andrea; HUTCHINGS, Martin; BIGGI, Alberto ... Journal of clinical oncology, 08/2007, Letnik: 25, Številka: 24
    Journal Article
    Recenzirano

    Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective trials to evaluate the prognostic role of ...
Celotno besedilo
Dostopno za: UL
3.
  • Lenalidomide versus investi... Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
    Trněný, Marek, Prof; Lamy, Thierry, Prof; Walewski, Jan, Prof ... The lancet oncology, 03/2016, Letnik: 17, Številka: 3
    Journal Article
    Recenzirano

    Summary Background Lenalidomide, an immunomodulatory drug with antineoplastic and antiproliferative effects, showed activity in many single-group studies in relapsed or refractory mantle cell ...
Celotno besedilo
Dostopno za: UL
4.
  • Chlamydophila Psittaci Erad... Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial
    FERRERI, Andrés J. M; GOVI, Silvia; POLITI, Letterio Salvatore ... Journal of clinical oncology, 08/2012, Letnik: 30, Številka: 24
    Journal Article
    Recenzirano
    Odprti dostop

    The pathogenic association between Chlamydophila psittaci (Cp) and ocular adnexal marginal zone lymphoma (OAMZL) and the efficacy of doxycycline monotherapy have been investigated in retrospective ...
Celotno besedilo
Dostopno za: UL

PDF
5.
Celotno besedilo
Dostopno za: UL
6.
  • Stem cell collection and he... Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial
    Clerico, Michele; Ferrero, Simone; Alessandria, Beatrice ... Scientific reports, 07/2024, Letnik: 14, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation ...
Celotno besedilo
Dostopno za: UL
7.
  • ABVD Compared With BEACOPP ... ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
    FEDERICO, Massimo; LUMINARI, Stefano; SCALONE, Renato ... Journal of clinical oncology, 02/2009, Letnik: 27, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    To compare doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) versus bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) versus ...
Celotno besedilo
Dostopno za: UL
8.
  • High rate of durable respon... High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study
    Mauro, Francesca R; Starza, Irene Della; Messina, Monica ... Haematologica, 08/2023, Letnik: 108, Številka: 8
    Journal Article
    Recenzirano
    Odprti dostop

    The GIMEMA phase II LLC1518 VERITAS trial investigated the efficacy and safety of front-line, fixed-duration venetoclax and rituximab (VenR) in combination in young (≤65 years), fit patients with ...
Celotno besedilo
Dostopno za: UL
9.
  • Prolonged survival in the a... Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
    Bruna, Riccardo; Benedetti, Fabio; Boccomini, Carola ... Haematologica, 11/2019, Letnik: 104, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) conventional chemotherapy with rituximab (CHOP-R) as ...
Celotno besedilo
Dostopno za: UL

PDF
10.
Celotno besedilo
Dostopno za: UL

PDF
1 2 3 4 5
zadetkov: 207

Nalaganje filtrov